그룹미야오EP2집'BITENOW'무드필름/더블랙레이블[마이데일리=김하영기자]그룹미야오(MEOVV)가더욱짙어진팀컬러를장착하고컴백한다.더블랙레이블은11일공식SNS를통해그룹미야오(수인·가원·안나·나린·엘라)의EP2집'BITENOW'발매소식을알리는무드필름을공개하며오는6월1일컴백을확정지었다.공개된무드필름은미야오의눈과실루엣을차례차례조명하며오묘한분위기를만들어내고있다.시선을사로잡는다섯멤버의'캣츠아이'는날카롭고부드러운고양이의매력을닮은팀아이덴티티를전달하며,완벽한비주얼케미스트리로기대감을끌어올리고있다.심플함과화려함이공존하는시크한스타일링,한층물오른표정연기등도미야오의컴백을더욱기대케한다.그동안무대위에서강렬한퍼포먼스와에너지를보여준것은물론,몽환적이고캐주얼한음악까지소화하며스펙트럼을넓혀온미야오가EP2집을통해어떤새로운변신을시도할지궁금해진다.미야오는지난해10월디지털싱글'BURNINGUP'(버닝업)으로활동하며강렬한음악과함께독보적인퍼포먼스로주목받았다.국내외차트에서호성적을거두며활동을마무리한미야오는다수의연말시상식에참석해트로피를추가하며5세대걸그룹선두주자의입지를공고히했다.미야오의EP2집'BITENOW'는오는6월1일오후6시발매된다.Copyright©마이데일리.무단전재및재배포금지.

'만학도지씨'넷플릭스‘만학도지씨’가미국-이란전쟁을쉽고현실적인시선으로풀어낸다.지석진과미미는역사스토리텔러썬킴과함께복잡한중동정세를눈높이토크로짚으며흥미와정보를동시에잡는다.11일공개되는넷플릭스일일예능‘만학도지씨’8회에는역사스토리텔러썬킴이출연해미국-이란전쟁과중동정세를집중분석한다.‘만학도지씨’에서지석진은“전쟁을잘모른다”며솔직한반응을보였고,미미는특유의엉뚱한질문으로분위기를이끌었다.이에썬킴은“실질적으로는이란과이스라엘의전쟁”이라며국제정세의배경을알기쉽게설명했다.특히썬킴은이스라엘총리베냐민네타냐후와도널드트럼프전미국대통령의관계를언급하며미국이전쟁에동조하게된흐름까지분석해시선을모았다.실감나는설명이이어지자지석진은“개그맨같다”며웃음을터뜨렸다는후문이다.또‘만학도지씨’에서는1979년이슬람혁명이후미국과이란이적대관계가된역사적배경과이란핵개발문제도다뤄진다.여기에유대인네트워크와글로벌정세까지연결되며몰입감을높일예정이다.썬킴은혁명수비대의탄생과정과호르무즈해협봉쇄가세계경제에미치는영향도쉽게설명한다.국제유가와글로벌경제흐름까지이어지는현실밀착형이야기로관심을끌전망이다.두바이를둘러싼흥미로운비하인드도공개된다.썬킴은“두바이는오일머니도시이미지와달리실제석유생산량은많지않다”고설명했고,미미는“두바이초콜릿이엄청잘팔릴텐데”라고반응해웃음을안겼다.지석진은“세계평화가와야주식시장도좋아진다”며투자이야기에몰입하는모습으로현장을폭소케했다.썬킴역시두사람의열공분위기에“굉장히고품격방송”이라고감탄했다.‘만학도지씨’는지식의문턱을낮춘현실밀착형지식예능으로꾸준한화제를모으고있다.특히시사와역사이슈를쉽고유쾌하게풀어내며젊은시청자들의관심을얻고있다.한편넷플릭스‘만학도지씨’8회는11일오후5시공개된다.사진제공=넷플릭스‘만학도지씨’서정민기자[email protected]©bnt뉴스.무단전재,재배포및AI데이터활용금지

TV조선(서울=뉴스1)장아름기자='조선의사랑꾼'한윤서가예비신랑과격렬한다툼을벌이는모습이포착됐다.11일오후방송되는TV조선'조선의사랑꾼'에서는결혼을준비중인개그우먼한윤서와예비신랑이다투는모습이공개된다.1986년생인한윤서는세는나이41세로,그간'노처녀콘텐츠'로많은사랑을받았으나최근'조선의사랑꾼'에서2세연상의예비신랑을소개하며주목받았다.TV조선선공개영상에서한윤서와예비신랑은이사준비과정에서쌓였던서운함을토로하며갈등의정점을찍었다.한윤서는"내가힘들게찾아본것에'왜이걸로했어?'이런이야기하지말았으면좋겠다"며그간쌓였던감정을드러냈다.이에예비신랑은"자기가요즘신경이예민하고날카롭다"며"말한마디가다날이서있다"고반박했다.또한"자기가인정하지않았나,자기되게공격적이다"라며"이걸대꾸하면또싸우게되니나혼자삭히는게더많다"고서운한마음을털어놨다.그러자한윤서도"이번주에예민한건맞다,나도많이삭힌다"면서도"밤에기도한다.'이결혼맞나?'라며나도기도한다"고속마음을고백해충격을안긴다.싸움은점점격해졌고결국예비신랑은자리를박차고나갔다.홀로남은한윤서는"어디가지?"라고당혹감을표해긴장감을더했다.과연두사람이갈등을잘봉합할수있을지본방송이더욱주목된다.'조선의사랑꾼'은각양각색사랑꾼들의좌충우돌러브스토리를날것그대로전하는극사실주의다큐예능으로,이날오후10시방송된다[email protected]©뉴스1.Allrightsreserved.무단전재및재배포,AI학습이용금지.

사진제공|KBS[스포츠동아이정연기자]김대호가10년째연애를쉬고있다고고백하며‘말자팅’을신청한다.11일방송되는KBS2‘말자쇼’는가족관련고민을주제로꾸며진다.이날아나운서출신방송인김대호가게스트로출연한다.김대호는과거한방송에서대가족이함께하는명절풍경을공개해화제를모았다.그는“머릿속에떠오르는친지들만50명”이라며“방송인김대호가아닌대가족의일원김대호로‘말자쇼’를즐겨보겠다”고말한다.이날김대호는가족고민해결사로도나선다.한번에40명이상모이는대가족이함께즐길수있는레크리에이션아이디어부터외모를지적하는부모님잔소리고민까지다양한사연에조언을건넨다.KBS를향한애정도드러낸다.김대호는“나는KBS의둘째아들”이라고말한다.이어KBS아나운서출신전현무를“집나간아들”이라고표현하며자신만의장점을내세운다.김대호가인정한‘KBS첫째아들’의정체도공개될예정이라궁금증을더한다.특히김대호는“내가족을꾸릴때가됐다”고털어놓는다.이어“연애를안한지10년이됐다”고고백해모두를놀라게한다.그는‘말자쇼’에서자연스러운만남을추구해보고싶다고요청한다.‘말자할매’김영희에게꿈꾸는이상형을밝히며‘말자팅’성사를기대하게한다.김대호가높은커플성사율을자랑하는‘말자팅’의기적을경험할수있을지는11일방송되는KBS2‘말자쇼’에서공개된다.이정연기자[email protected]©스포츠동아.무단전재및재배포금지.

[스타뉴스|김노을기자]김태현,최연수/사진=최연수인스타그램최현석셰프딸최연수가조기출산에대해해명했다.최연수는10일자신의SNS에한누리꾼의댓글캡처본을게재했다.해당누리꾼은최연수의출산소식을접한후"요즘에는아기를2kg대에낳아버리는구나.그럼보통32주에서35주사이에강제로꺼내는건가"라고궁금증을표했다./사진=최연수인스타그램이어"어쩐지,40주1일자연분만으로태어난우리애빼고는조리원에있는산모들전부제왕절개였고1주먼저나온아기들이우리애보다작았으니맞구나"라고전했다.이에최연수는대댓글기능을통해"아니다.다그런게아니고저는임신중독증이올수도있을정도로높은혈압이라고위험산모로입원을했다.고혈압으로인해양수도부족했다"고상황을설명했다.또한"혈압도높아지고양수도부족해서급하게낳은거다.분만예정일은6월1일이었다"고밝혔다.최연수는지난해9월12세연상의밴드딕펑스멤버김태현과결혼했으며최근득남했다.김노을기자[email protected]©스타뉴스&starnewskorea.com,무단전재및재배포금지

방송인박나래씨가지난2월20일서울강남경찰서를나서며취재진질문을받고있다.연합뉴스방송인박나래가전직매니저들과의얽히고설킨법적공방과불법의료행위의혹으로이달중세번째경찰조사를받는다.지난2월과3월에이은추가소환으로,수사가막바지단계에접어든양상이다.11일방송가와경찰등에따르면서울강남경찰서는특수상해와명예훼손,정보통신망법위반및의료법위반혐의를받는박씨를소환해조사할방침이다.이번사태는지난해12월전매니저들이박씨로부터폭언과폭행을당했다고주장하는한편,이른바‘주사이모’를통한대리처방및불법시술의혹을제기하며고소장을제출하면서시작됐다.이과정에서다른동료연예인들의이름까지거론되며연예계전반으로파장이확산했다.박씨측은관련의혹을전면부인하며강력히맞서고있다.박씨측은오히려전매니저들이허위사실로협박했다며이들을공갈미수와업무상횡령혐의로맞고소한상태다.현재이사건과관련해강남경찰서6건,용산경찰서2건등총8건의고소·고발사건이복잡하게얽혀수사가진행중이다.특히,핵심쟁점중하나인의료법위반의혹을두고양측의입장은극명하게엇갈린다.박씨측은“의료진의처방에따른합법적인영양제투약이었다”고주장하고있으나,의료계일각에서는해당시술자의면허유무와실체에의문을제기하고있어경찰이이부분을집중적으로들여다볼것으로보인다.박씨는앞선조사에서“경찰조사에성실히임하고있으며사실이아닌부분은명확히바로잡겠다”는입장을밝힌바있다.이승주기자Copyright©문화일보.무단전재및재배포금지.

김대호,뉴스엔DBKBS2TV‘말자쇼’제공[뉴스엔김명미기자]방송인김대호가10년째솔로라고밝혔다.5월11일방송되는KBS2TV'말자쇼'게스트로는아나운서출신방송인김대호가출격한다.한방송에서대가족이함께하는명절풍경을공개해화제를모았던김대호는이날"머릿속에떠오르는친지들만50명"이라며"방송인김대호가아닌대가족의일원김대호로'말자쇼'를즐겨보겠다"라고밝힌다.이날김대호는"나는KBS의둘째아들"이라고언급,KBS아나운서출신전현무는'집나간아들'이라고지적한다.이어김대호는자신이전현무보다나은장점을설명한다.과연김대호가인정하는첫째아들은누구일지도궁금증을자극한다.특히김대호는"내가족을꾸릴때가됐다.하지만연애를안한지10년이됐다"라고고백한다.그는'말자쇼'에서자연스러운만남을추구해보고싶다고요청하며'말자할매'김영희에게꿈에그리는이상형을전한다.과연김대호의이상형은어떤여성일지주목된다.한편김대호는과거MBC'나혼자산다'를통해대가족의명절을공개해'결혼장례식'을치렀다는반응을얻은바있다.김대호는가족이김장철에무려1400포기나김장을한적있다고밝히기도했다.뉴스엔김명미mms2@기사제보및보도자료[email protected]ⓒ뉴스엔.무단전재&재배포금지Copyright©뉴스엔.무단전재및재배포금지.

ThisarticlewasreleasedasPharmEdailyPremiumContentonMay8,2026,at11:40AM.[JiwanKim,EdailyReporter]KoreanpharmaceuticalandbiotechsharesmovedsharplyhigheronMay7ascompaniesannouncedpositiveglobalclinicaldataandU.S.FDA-relateddevelopmentsacrossobesity,ophthalmology,andoncologysectors.Investorsrespondedstronglytosignsthatseveraldomesticfirmsaremovingbeyondearly-stageR&Dintoglobalcommercializationandlicensingdiscussions.DreamCIShitthedailyupperlimitafteritspartnerreportedsuccessfulglobalPhase3resultsforanobesitytreatmentcandidate.ReyonPharmaceuticalsurgedonlong-termefficacydataforawetage-relatedmaculardegeneration(wAMD)genetherapy,whilePolarisAIPharmagainedafterinvesteeAlphaTauMedicalobtainedFDAapprovaltoexpandapancreaticcancerclinicaltrial.DreamCISSoarsonGlobalPhase3SuccessofObesityDrugCandidateDreamCISclosedup29.8%at6,250wonafterBrightgeneBio-MedicalannouncedthatitsGLP-1/GIPdualagonistobesitydrugcandidate“BGM0504”achievedprimaryendpointsinaglobalPhase3study.Therandomized,double-blind,placebo-controlledtrialenrolled652overweightandobesepatientsacross41clinicalsitesinChina.Participantshadanaveragebaselinebodyweightof96.2kgandameanBMIof33.9kg/m².Accordingtothecompany,BGM0504achievedanaverage19.3%weightreductionat52weeks.Inadditiontoweightloss,thedrugdemonstratedbroadcardiometabolicbenefits.Amongpatientswithhypertension,92.9%reportedlyreturnedtonormalbloodpressureranges.Hipbonedensityincreasedbyanaverageof3.9%despitesubstantialweightreduction,andnohypoglycemiacaseswerereportedduringthestudy.Safetydataalsoattractedattention.Thediscontinuationrateduetoadverseeventsinthehigh-dose15mggroupwasonly0.7%,suggestingpotentiallyimprovedtolerabilitycomparedwithexistingGLP-1therapies,whichareoftenassociatedwithgastrointestinalsideeffectsandtreatmentdropouts.TheglobalobesitydrugmarketiscurrentlydominatedbyEliLilly’sMounjaro/ZepboundandNovoNordisk’sWegovy.MarketobserversarenowwatchingwhetherBGM0504candifferentiateitselfthroughbothweightreductionandbroadermetabolicbenefits.DreamCISsaidithasindependentlysubmittedanINDapplicationfordomesticPhase3trialsinKoreaandisseekingexclusivecommercializationanddistributionrightsfortheKoreanmarket.ReyonPharmaceuticalClimbsonLong-TermGeneTherapyDataReyonPharmaceuticalrose9.02%tocloseat11,240wonafterannouncing52-weekfollow-updatafor“NG101,”agenetherapytargetingwetage-relatedmaculardegenerationco-developedwithElysigen.ThedatawerepresentedatARVO2026,oneoftheworld’slargestophthalmologyconferences,heldthisyearinDenver.Accordingtothepresentation,patientsinthelow-dosecohortrequiredanaverageof9.8anti-VEGFinjectionsduringtheyearpriortotreatment.AfterreceivingNG101,theaveragenumberofinjectionsfellto1.1duringthe52-weekfollow-upperiod,representinganapproximately89%reductionininjectionburden.Thedurabilityprofilealsoappearedencouraging.Fiveoutofsixpatientsmaintainedvisionwithoneorfeweradditionalinjectionsoveroneyear,whilethreepatientsrequirednosupplementaryanti-VEGFinjectionsatallduringtheobservationperiod.Noseriousadverseevents(SAE)ordose-limitingtoxicities(DLT)wereobservedduringthestudy.ReyonPharmaceuticalandElysigencompleteddosingforall20patientsenrolledinthePhase1/2astudyandplantosecureinterimdatainthethirdquarterof2026beforeadvancingintoglobalPhase2btrialsandlicensingnegotiations.ReyonPharmaceuticalsecuredexclusiveglobalmanufacturingandsupplyrightsforNG101undera2020co-developmentagreementwithElysigen.Thecompany’ssmartfactoryinChungjuisexpectedtoserveasafutureproductionhubforcommercialization.ReyonPharmaceutical’sChungjuBioPlant.(Photo=ReyonPharmaceutical)PolarisAIPharmaGainsonFDAApprovalforAlphaTauTrialExpansionPolarisAIPharmaclimbed8.02%to7,540wonafterAlphaTauMedicalreceivedFDAapprovalforanIDEsupplementrelatedtoitspancreaticcancerprogram.TheapprovalallowsAlphaTautoexpandenrollmentinitsU.S.multicenterIMPACTpilotstudybyaddingagemcitabine/nab-paclitaxelcombinationarmalongsidetheexistingmFOLFIRINOXcohort.Asaresult,thetotalstudysizewillincreasefrom30to40patients,includingnewlydiagnosedunresectablelocallyadvancedandmetastaticpancreaticcancerpatients.AlphaTauExpandsU.S.PancreaticCancerTrialAfterFDAApprovesIDESupplement.(Source:AlphaTau)Thestudyisevaluating“AlphaDaRT,”alocalizedradiationplatformbasedonradium-224.Thetechnologyisdesignedtoemithigh-energyalphaparticlesdirectlyinsidetumorswhileminimizingdamagetosurroundinghealthytissuesduetotheshorttraveldistanceofalpharadiation.AlphaTauCEOUziSoferdescribedtheFDAdecisionasanimportantsteptowarddevelopingnewtreatmentoptionsforoneofthedeadliestcancers.Thecompanyexpectspatientenrollmenttobecompletedinthethirdquarterof2026.ChiefMedicalOfficerRobertDensaidtheexpandeddesignwouldallowAlphaTautoevaluateAlphaDaRTacrossbothmajorfirst-linestandard-of-careregimensforpancreaticcancer,strengtheningthecompany’sdevelopmentpathway.김지완([email protected])Copyright©이데일리.무단전재및재배포금지.

티브이데일리포토[티브이데일리김지현기자]배우강성연이새로운가정을꾸린사실을직접알렸다.강성연은10일밤개인SNS를통해재혼상대의모습을공개하며팬들에게근황을전했다.그는게시글에서자신의아픈마음을지켜준남편덕분에다시웃을수있게되었다며배우자에대한깊은신뢰를표현했다.강성연은자신과아이들이좋은인연을만나평범하고귀한행복을만들어가는중이라고밝혔다.소식을전하는방식에대해고민이많았으나,어떻게지내는지정확히알리는것이중요하다는생각에용기를냈다고덧붙였다.가정의달을맞이한소회도언급했다.고령의부모님을둔막내딸이자초등학생두아들의엄마,그리고한가정의아내로서본인의행복이가장중요하다는것을깨달았다고강조했다.이어팬들의응원에힘입어더행복하게살겠다는다짐을전했다.공개된사진에는제주도여행중남편과함께미소를짓고있는강성연의모습이담겼다.강성연은지난2012년첫결혼후두자녀를얻었으나2023년12월이혼소식을전한바있다.[티브이데일리김지현기자[email protected]]강성연[Copyrightⓒ*세계속에新한류를*연예전문온라인미디어티브이데일리(www.tvdaily.co.kr)/무단전재및재배포금지]Copyright©티브이데일리.무단전재및재배포금지.

'소라와진경'방송방송시청후작성된리뷰기사입니다.[OSEN=최지연기자]모델겸방송인홍진경이유재석을향한팬심을드러냈다.지난10일오후9시10분방송된MBC‘소라와진경’(연출강성아·장하린·윤동욱,작가신재경)에서는파리현지에이전시면접때문에홍진경의집을찾은이소라가그려진가운데특별한물건을발견해웃음을안겼다.이소라와홍진경은파리현지에이전시와영어로온라인면접을해야해서각자지원군들을만나인터뷰를준비했다.이소라의지원군은성시경,백진경이었고,홍진경은딸라엘이와함께예상질문과대답을만들었다.대망의면접당일,홍진경의집을찾은이소라는백진경에서배운'뱀'(Baaam)을전파했다.그러나홍진경은웃음만짓다"언니가먼저면접봐라.하고싶은거다해봐라"라고호응했다.이후둘은"영어실력이빨리좋아지려면연인을사귀어야한다"는결론을내리고는서로의과거연애사를훑었다.이소라는"언니는너무오래살았어"라며국제연애를해본적있다고긍정,과거연인의나라가프랑스와관련있다고설명했다.'소라와진경'방송그런가하면이소라는홍진경과식사를마친후이동하다거실에놓인유재석의사진을보았다.이소라는"왜저렇게뒀어?"라고물었다.홍진경은"방송용소품이었다.그냥재석이오빠얼굴을보면신나니까가져왔다"고대답해놀라움을자아냈다.이때이동휘또한"저도재석이형사진이집에있다"고공감하더니"그냥살아계신게너무많은도움이된다"고너스레를떨었다.이를들은김원훈은"저도동엽선배님얼굴이테이블위에환하게있다"고롤모델인신동엽을언급했다.그러자신동엽과과거공개연애를했던이소라는"지금그얘기가꼭필요하냐"고지적해웃음을안겼다./[email protected][사진]'소라와진경'방송Copyright©OSEN.무단전재및재배포금지.

KBS2TV'사장님귀는당나귀귀'(엑스포츠뉴스김유진기자)전야구선수양준혁이스포츠센터사업을정리했다고밝혔다.10일방송된KBS2TV예능'사장님귀는당나귀귀'(이하'사당귀')에서는처가를방문한양준혁의모습이그려졌다.이날양준혁은장모에게"방어사업도괜찮고,야구에서도불러주는데가많다"고당당하게말했다.이를듣고있던장모는"전에도망한사업이있냐"고물었다.KBS2TV'사장님귀는당나귀귀'이에잠시고민하던양준혁은"8년전에(서울강남구)개포동에서야구센터를8년정도했었다.그런데월세도비싸고,계약만료가돼서접었다"고말했다.이어"월세가워낙비쌌다.1500만원이었다"고밝혔다.스튜디오에서영상을보던김숙은"가만히만앉아있어도1500만원이나가는거냐"고놀랐다.KBS2TV'사장님귀는당나귀귀'이에양준혁은"강남이라자리월세,임대료가비쌌다.내가애들을잘가르쳐서인기는좋았다"고웃었다.앞서양준혁은3000평양식장에서대방어양식사업중인근황을전하며연매출이30억정도라고밝힌바있다.또이를위해선수시절벌었던돈을쏟아부었고,그과정에서50억원가량을잃었다고고백했다.사진=KBS2TV방송화면김유진기자[email protected]©엑스포츠뉴스.무단전재및재배포금지.

[텐아시아=이소정기자]'21세기대군부인'공승연이냉혹한결단력과가슴깊은상처를동시에그려내며극의텐션을정점으로끌어올렸다./사진=MBC방송화면캡처'21세기대군부인'공승연이냉혹한결단력과가슴깊은상처를동시에그려내며극의텐션을정점으로끌어올렸다.지난8,9일방송된MBC금토드라마'21세기대군부인'9,10회에서는이안대군(변우석분)부부의계약결혼파문과선왕이환(성준분)의교지를둘러싼진실이수면위로떠오르며왕실이거센혼란에직면한가운데,아들윤의왕좌를수호하려는대비윤이랑(공승연분)의위태로운내면변화가긴박하게펼쳐졌다.'21세기대군부인'공승연이냉혹한결단력과가슴깊은상처를동시에그려내며극의텐션을정점으로끌어올렸다./사진=MBC방송화면캡처윤이랑은이안대군과성희주(아이유분)의계약결혼이폭로되자종친부를즉각소집해두사람을강하게몰아붙였다.윤의자리를지키기위해오랜시간이안대군을경계해온윤이랑은이번사태를계기로더욱냉혹한면모를보였지만,동시에나타난선왕의양위교지와과거화재사건의진상이윤이랑을거센혼란속으로밀어넣었다.아들윤의왕위를지키기위한자신의선택들이오히려윤을내몰았다는잔혹한현실앞에서윤이랑은무너져내리는듯했다.이과정에서아버지윤성원(조재윤분)과의대면을통해드러난상처와이안대군을향한복합적인감정은극의긴장감을극대화했다.또혼란속에서성희주를신경쓰는듯한미묘한움직임은향후전개에대한궁금증을증폭시켰다.이날공승연은왕권을지키기위해모든것을내던진윤이랑의처절한감정선을밀도높게소화하며독보적인화면장악력을발휘했다.냉정함을잃지않는대비로서의위엄을보이다가도,이안대군의결단으로인해입지가흔들리자아들에대한애처로운마음과억눌러왔던과거의상처가뒤섞인인물의내면을섬세하게풀어냈다.왕실의권위를실추시킨이안대군내외를추궁하는장면에서는서늘한눈빛과절도있는어조로분위기를압도했고,선왕의교지와관련해윤성원의의심을받는순간에는폭발적인감정을억누르는절제된호흡으로윤이랑의심정을고스란히전달했다.'21세기대군부인'공승연이냉혹한결단력과가슴깊은상처를동시에그려내며극의텐션을정점으로끌어올렸다./사진=MBC방송화면캡처무엇보다아들윤을품에안고통곡하는장면은시청자들에게깊은인상을남기기충분했다.그간홀로감내해온압박감과더불어,왕위수호를위해스스로를희생했으나결국가장소중한존재에게상처를주었다는비참함을공승연만의깊이있는연기력으로설득력있게완성해냈다.여기에왕립학교시절,이안대군을향한연모의감정을뒤로한채세자빈이되어야했던과거서사는현재의차가운모습과극명한대비를이루며캐릭터의풍성함을더했다.순수했던과거와위태로운현재를자유자재로오가는공승연의열연은극의중심을단단히지탱했다.뿐만아니라총리민정우(노상현분)와대치하며느끼는미세한불안감,성희주를향한일말의걱정은윤이랑이라는인물이단순한악역이아닌입체적인서사를지닌캐릭터임을여실히증명하기도.방송말미에는윤이랑의새로운행보가암시되며또다른파란을예고했다.아들윤의자리를보존하기위해스스로를몰아붙여온윤이랑이어떤마지막선택을하게될지관심이집중되는가운데,종영까지단2회만을남겨둔공승연주연의드라마'21세기대군부인'은매주금,토요일밤9시50분MBC에서방송된다.이소정텐아시아기자[email protected]©텐아시아.무단전재및재배포금지.